Welcome to Consumer Reports Advocacy

For 85 years CR has worked for laws and policies that put consumers first. Learn more about CR’s work with policymakers, companies, and consumers to help build a fair and just marketplace at TrustCR.org

Letter to the FDA requesting Takeda immediately cease the dissemination of violative promotional materials for Rozerem

CU hopes that the FDA will support legislation in Congress during the PDUFA user fee debate and the debate on Kennedy-Enzi (S. 484) to add language that will strengthen the requirements for timely, mandatory pre-approval of ads, civil monetary penalties for violations (especially repeat violations), and the more frequent placement of corrective ads so as to prevent abuse.